BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 25376109)

  • 21. Lipotoxicity, aging, and muscle contractility: does fiber type matter?
    Carter CS; Justice JN; Thompson L
    Geroscience; 2019 Jun; 41(3):297-308. PubMed ID: 31227962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sarcopenic obesity.
    Polyzos SA; Margioris AN
    Hormones (Athens); 2018 Sep; 17(3):321-331. PubMed ID: 30014320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sarcopenia and sarcopenic obesity among men aged 80 years and older in Beijing: prevalence and its association with functional performance.
    Meng P; Hu YX; Fan L; Zhang Y; Zhang MX; Sun J; Liu Y; Li M; Yang Y; Wang LH; Zhang Y; Gao W; Han XQ; Chen LK
    Geriatr Gerontol Int; 2014 Feb; 14 Suppl 1():29-35. PubMed ID: 24450558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frailty and sarcopenia as the basis for the phenotypic manifestation of chronic diseases in older adults.
    Angulo J; El Assar M; Rodríguez-Mañas L
    Mol Aspects Med; 2016 Aug; 50():1-32. PubMed ID: 27370407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sarcopenia.
    Thomas DR
    Clin Geriatr Med; 2010 May; 26(2):331-46. PubMed ID: 20497850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanisms in aging and current strategies to counteract sarcopenia.
    Sakuma K; Yamaguchi A
    Curr Aging Sci; 2010 Jul; 3(2):90-101. PubMed ID: 20158492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between Sarcopenic Obesity and Pulmonary Function in Korean Elderly: Results from the Korean National Health and Nutrition Examination Survey.
    Lee SE; Park JH; Kim KA; Kang YS; Choi HS
    Calcif Tissue Int; 2020 Feb; 106(2):124-130. PubMed ID: 31642952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sarcopenia, obesity, and natural killer cell immune senescence in aging: altered cytokine levels as a common mechanism.
    Lutz CT; Quinn LS
    Aging (Albany NY); 2012 Aug; 4(8):535-46. PubMed ID: 22935594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sarcopenic Obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives.
    Koliaki C; Liatis S; Dalamaga M; Kokkinos A
    Curr Obes Rep; 2019 Dec; 8(4):458-471. PubMed ID: 31654335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sarcopenia and obesity.
    Zamboni M; Rubele S; Rossi AP
    Curr Opin Clin Nutr Metab Care; 2019 Jan; 22(1):13-19. PubMed ID: 30461451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis.
    Perrini S; Laviola L; Carreira MC; Cignarelli A; Natalicchio A; Giorgino F
    J Endocrinol; 2010 Jun; 205(3):201-10. PubMed ID: 20197302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testosterone Deficiency and Testosterone Treatment in Older Men.
    Saad F; Röhrig G; von Haehling S; Traish A
    Gerontology; 2017; 63(2):144-156. PubMed ID: 27855417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sarcopenic obesity and complex interventions with nutrition and exercise in community-dwelling older persons--a narrative review.
    Goisser S; Kemmler W; Porzel S; Volkert D; Sieber CC; Bollheimer LC; Freiberger E
    Clin Interv Aging; 2015; 10():1267-82. PubMed ID: 26346071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bariatric Surgery Outcomes in Sarcopenic Obesity.
    Mastino D; Robert M; Betry C; Laville M; Gouillat C; Disse E
    Obes Surg; 2016 Oct; 26(10):2355-62. PubMed ID: 26926186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential mechanisms underlying the role of chronic inflammation in age-related muscle wasting.
    Jo E; Lee SR; Park BS; Kim JS
    Aging Clin Exp Res; 2012 Oct; 24(5):412-22. PubMed ID: 22717404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal associations between body composition, sarcopenic obesity and outcomes of frailty, disability, institutionalisation and mortality in community-dwelling older men: The Concord Health and Ageing in Men Project.
    Hirani V; Naganathan V; Blyth F; Le Couteur DG; Seibel MJ; Waite LM; Handelsman DJ; Cumming RG
    Age Ageing; 2017 May; 46(3):413-420. PubMed ID: 27932368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscle quality as a potential explanation of the metabolically healthy but obese and sarcopenic obese paradoxes.
    Barbat-Artigas S; Filion ME; Plouffe S; Aubertin-Leheudre M
    Metab Syndr Relat Disord; 2012 Apr; 10(2):117-22. PubMed ID: 22182254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sarcopenia and obesity.
    Waters DL; Baumgartner RN
    Clin Geriatr Med; 2011 Aug; 27(3):401-21. PubMed ID: 21824555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The prevalence of sarcopenic obesity in postmenopausal women in depending on the used methodology - preliminary study].
    Milewska M; Sińska B; Sych D; Kucharska A
    Pol Merkur Lekarski; 2015 Apr; 38(226):206-10. PubMed ID: 25938387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities.
    Cleasby ME; Jamieson PM; Atherton PJ
    J Endocrinol; 2016 May; 229(2):R67-81. PubMed ID: 26931135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.